Daiichi Sankyo submits application for marketing approval of mRNA COVID vaccine DS-5670 in Japan Ruchika Sharma15 Jan 2023 9:00 AM ISTTokyo: Daiichi Sankyo has announced the submission of an application for marketing approval of DS-5670 to the regulatory authorities in Japan.DS-5670...
Daiichi Sankyo unveils Blood cancer drug EZHARMIA in Japan Ruchika Sharma21 Dec 2022 4:00 PM ISTAdult T-cell leukemia-lymphoma (abbreviated ATLL or ATL) is a rare and aggressive hematologic malignancy that is caused by human T-cell lymphotropic...
Experts say patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement Ruchika Sharma10 Dec 2022 1:30 PM ISTUK: The rush to use AstraZeneca and Daiichi-Sankyo's drug Enhertu to treat certain types of breast cancer has far outpaced doctors' ability to...
Daiichi Sankyo ENHERTU gets Japanese nod for patients with previously treated HER2 Positive Metastatic Breast Cancer Ruchika Sharma25 Nov 2022 1:30 PM ISTENHERTU (trastuzumab deruxtecan, fam-trastuzumab deruxtecan-nxki in the U.S. only) is a HER2 directed ADC.
AstraZeneca- Daiichi Sankyo Enhertu recommended for nod in EU by CHMP for patients with previously treated HER2-positive advanced gastric cancer Ruchika Sharma15 Nov 2022 12:15 PM ISTEnhertu is a HER2-directed ADC.
California Court orders in favor of Plexxikon in dispute with Novartis Ruchika Sharma4 Oct 2022 6:00 PM ISTTokyo: Daiichi Sankyo has announced that the U.S. District Court for the Northern District of California has issued an order sustaining a jury...
AstraZeneca, Daiichi Sankyo get USFDA nod for Enhertu for earlier breast cancer use Ruchika Sharma6 May 2022 5:08 PM ISTThe approval was granted under the FDA's Real-Time Oncology Review (RTOR) programme and converts the accelerated approval of Enhertu in later line...
Daiichi Sankyo gets Japenese nod for Tarlige tablets to treat neuropathic pain Ruchika Sharma31 March 2022 9:45 AM ISTTokyo: Daiichi Sankyo Company, Limited has announced that the company has obtained approval in Japan to change the indication of the analgesic...
Daiichi Sankyo submits NDA for Lymphoma treatment Valemetostat in Japan Ananya Shrivastava2 Jan 2022 10:45 AM ISTTokyo: Daiichi Sankyo Company, Limited has announced that it has submitted a New Drug Application (NDA) to Japan's Ministry of Health, Labour and...
Daiichi Sankyo gets approval for additional indication of Antiplatelet Agent Efient in Japan Ruchika Sharma27 Dec 2021 5:38 PM ISTTokyo: Daiichi Sankyo Company, Limited has announced that the company has obtained a supplemental new drug application approval for additional...
SC asks Fortis to submit details of Rs 4000 crores IHH deal, Singh brothers role by March 1 MD Bureau26 Feb 2021 9:30 AM ISTNew Delhi: In the latest update regarding the Fortis Healthcare Row, the Supreme Court of India, on Wednesday, has asked the company to provide the...
Daiichi Sankyo names Ken Takeshita as Global Head of RnD Ruchika Sharma24 Feb 2021 2:48 PM ISTTokyo & Munich & Basking Ridge, N.J.: Daiichi Sankyo Company, Limited has recently announced Ken Takeshita, MD will be named the new Global...
